Cargando…
A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria
Plasmodium vivax malaria continues to cause a significant burden of disease in the Asia-Pacific, the Horn of Africa, and the Americas. In addition to schizontocidal treatment, the 8-aminoquinoline drugs are crucial for the complete removal of the parasite from the human host (radical cure). While we...
Autores principales: | Sadhewa, Arkasha, Cassidy-Seyoum, Sarah, Acharya, Sanjaya, Devine, Angela, Price, Ric N., Mwaura, Muthoni, Thriemer, Kamala, Ley, Benedikt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220632/ https://www.ncbi.nlm.nih.gov/pubmed/37242320 http://dx.doi.org/10.3390/pathogens12050650 |
Ejemplares similares
-
Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure
por: Thriemer, Kamala, et al.
Publicado: (2021) -
Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
por: Rahmalia, Annisa, et al.
Publicado: (2023) -
Improving the Radical Cure of Plasmodium vivax Malaria
por: Price, Ric N.
Publicado: (2014) -
Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh
por: Engel, Nora, et al.
Publicado: (2021) -
Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
por: Poespoprodjo, Jeanne Rini, et al.
Publicado: (2022)